A Prospective Double-Blind Randomized Trial of Urokinase Flushes to Prevent Bacteremia Resulting From Luminal Colonization of Subcutaneous Central Venous Catheters
- 1 December 2002
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Pediatric Hematology/Oncology
- Vol. 24 (9), 710-713
- https://doi.org/10.1097/00043426-200212000-00005
Abstract
This study was undertaken to determine if central venous catheter (CVC)-related infection in children with cancer could be prevented by monthly flushing of the catheter with urokinase. Between August 1994 and July 1998, 103 patients with cancer were randomized at the time of subcutaneous CVC placement to receive monthly flushing of their catheters with either 5000 IU of urokinase–heparin or heparin alone. Patients subsequently had blood cultures taken from their CVCs during an episode of fever. Seventy-four of the 103 patients (72%) enrolled in the study received at least 6 catheter flushes: 40 with urokinase–heparin and 34 with heparin. The median number of flushes was 9.5 in the urokinase–heparin group and 10.2 in the heparin-only group (P = 0.62). There were 5 positive blood cultures in the urokinase–heparin group and seven in patients receiving heparin alone (P = 0.27). Staphylococcus epidermidis was isolated from the blood of 3 patients receiving urokinase–heparin and 6 in those receiving heparin alone (P = 0.17). Prophylactic monthly catheter flushes with 5000 IU urokinase did not significantly decrease the number of documented bacteremic events in children with cancer who have CVCs.Keywords
This publication has 32 references indexed in Scilit:
- Central Venous Catheter Use and the Risk of Infection in Children With Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 1999
- Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC)Transfusion Science, 1997
- Infectious Rates of Central Venous Pressure Catheters: Comparison Between Newly Placed Catheters and Those That Have Been ChangedMayo Clinic Proceedings, 1996
- Complications of indwelling venous access devices in cancer patients.Journal of Clinical Oncology, 1995
- Venous access in pediatric oncology patientsSeminars in Surgical Oncology, 1993
- Infectious risks of Broviac catheters in children with neoplastic diseasesThe Pediatric Infectious Disease Journal, 1992
- Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms.Journal of Clinical Oncology, 1990
- A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients.Journal of Clinical Oncology, 1989
- An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trialAmerican Journal Of Medicine, 1988
- Frequency of Broviac Catheter Infections in Pediatric Oncology PatientsThe Journal of Infectious Diseases, 1986